Sponsor: Cortez Masto
Party: Catherine [Sen.-D-NV] (Submitted 04/03/2025)

-- AMENDMENT TEXT --

[Page S2228]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
  SA 1560. Ms. CORTEZ MASTO submitted an amendment intended to be 
proposed by her to the concurrent resolution H. Con. Res. 14

establishing the congressional budget for the United States Government 
for fiscal year 2025 and setting forth the appropriate budgetary levels 
for fiscal years 2026 through 2034; which was ordered to lie on the 
table; as follows:
       At the appropriate place
insert the following:
     SEC. ___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO LOWERING 
                   PRESCRIPTION DRUG PRICES.
       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees

     aggregates
and other appropriate levels in this resolution

     and make adjustments to the pay-as-you-go ledger
for one or 
     more bills
joint resolutions
amendments
amendments between 
     the Houses
motions
or conference reports relating to 
     lowering prescription drug prices
which may include imposing 
     monetary penalties on drug manufacturers with respect to 
     prescription drug sales in the commercial market if the 
     average price of such drugs increases faster than the rate of 
     inflation or implementing other policies that penalize drug 
     manufacturers for increasing drug prices faster than 
     inflation
by the amounts provided in such legislation for 
     those purposes
provided that such legislation would not 
     increase the deficit over the period of the total of fiscal 
     years 2025 through 2034.
                                 ______

04/03/2025
Senate amendment submitted
